Prescription Drug Affordability Board; established.

File SB271 ("Prescription Drug Affordability Board; established.") was vetoed. Last action: May 19, 2026.

Virginia file SB271, before the Virginia Legislature. Vetoed as of 2026-05-19.

Official summary

Prescription Drug Affordability Advisory Panel established; maximum fair price; annual reports; civil penalties. Directs the Secretary of Health and Human Resources to establish the Prescription Drug Affordability Advisory Panel to conduct data analyses, develop policy recommendations, and identify implementation barriers related to strategies to improve prescription drug affordability, enhance price transparency, and strengthen data collection practices for prescription drugs across public and private payers. The bill requires the Panel to (i) report annually on prescription drug pricing trends and any policy recommendations on legislation to improve prescription drug affordability and (ii) provide quarterly updates on prescription drug pricing trends. The bill requires each pharmacy benefits manager to provide to the Panel, upon request, certain information relating to the dispensation of a referenced drug, as defined in the bill. The bill prohibits prescription drug manufacturers or wholesale distributors permitted or licensed in the Commonwealth from accepting payment at an amount higher than the maximum fair price established by the U.S. Secretary of Health and Human Services

How they voted

Yes (128)

No (12)

Read the official record for SB271

See everything up for a vote · This week in Virginia · See what we have filed with the clerk